Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PCBP3 antisense RNA 1 (PCBP3-AS1)
- Target
- PCBP3-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), ncRNA
01
Overview
PCBP3 antisense RNA 1 (PCBP3-AS1) is a long noncoding RNA gene located on human chromosome 21. It is transcribed from the opposite (antisense) strand relative to the PCBP3 gene. As a member of the lncRNA class, its transcript is not translated into protein but may play roles in regulating gene expression, RNA stability, or protein interactions. Currently, its specific biological activities and clinical relevance are not well defined, and it is chiefly noted in genomic databases rather than functional studies. PCBP3-AS1 is distinct from PCBP3 (Poly(rC)-binding protein 3), which is a protein-coding gene with known RNA-binding activity and some disease associations. Antisense RNAs often regulate their sense counterparts (here, PCBP3) at the transcriptional or post-transcriptional level, but there is no direct experimental data for PCBP3-AS1’s role in human health or disease.
- Other names
- PCBP3-AS1GC21M047222GC21M047485GC21M047809
02
Mechanism of action
Not applicable; no drugs known to target PCBP3-AS1.
03
Biological functions
Not well-characterized; likely acts in gene regulation as an antisense RNA, possibly modulating expression of the PCBP3 gene or interacting with RNA-binding proteins. No direct evidence of other specific functions.
04
Disease associations
No definitive disease associations reported for PCBP3-AS1 specifically. Antisense lncRNAs can sometimes play roles in cancer or other diseases via regulation of gene expression, but no concrete data for PCBP3-AS1.
Beyond the preview
Go deeper on PCBP3 antisense RNA 1 (PCBP3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PCBP3 antisense RNA 1 (PCBP3-AS1).